News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News Proximity to Physical Activity Facilities May Play Role in Body Fat Levels Michael O'Riordan December 13, 2017
News Daily News PCSK9 Inhibitors: More Data Show Disappointing Approval Rates of Prescriptions by Payers Yael L. Maxwell October 30, 2017
News Daily News More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA Michael O'Riordan October 24, 2017
News Daily News Evolocumab ‘Abjectly Fails’ Another Financial Stress Test Michael O'Riordan October 19, 2017
News Daily News Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute Michael O'Riordan October 10, 2017
News Daily News ACC Updates Recommendations for Non-statin Therapy Use for LDL-Cholesterol Lowering in Secondary Prevention Yael L. Maxwell September 06, 2017
News Daily News Evolocumab Not Cost-Effective at Current List Price Michael O'Riordan August 23, 2017
News Daily News Many Stroke Patients Stop Statins or Never Start, With Dire Consequences Michael O'Riordan August 02, 2017
News Conference News SCCT 2017 Coronary Calcium Scores in 2017: Useful, Yes, but Hard Outcomes Data Still Lacking Yael L. Maxwell July 13, 2017
Presentation SCCT 2017 Calcium Progression and Warranty Periods: A Role for Repeat Scanning Presenter: Matthew Budoff July 13, 2017
News Conference News SCCT 2017 Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See? Yael L. Maxwell July 10, 2017
News Conference News EAS 2017 EAS Consensus Document Strives to Banish Skepticism Over LDL Cholesterol’s Causal Role in Atherosclerosis Yael L. Maxwell April 24, 2017
News Conference News ACC 2017 Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them Yael L. Maxwell March 23, 2017
News Daily News Apples and Pears: Genetic Analysis Points to Causal Role for Belly Fat in Heart Disease and Diabetes Yael L. Maxwell February 14, 2017
News Daily News Alirocumab to Remain On Market While Companies Clash Over Patents Michael O'Riordan February 09, 2017